Suggestions
Jerry Rosenbaum
Director Center for the Neuroscience of Psychedelics at Massachusetts General Hospital Research Institute
Jerry Rosenbaum is a prominent figure in the field of psychiatry and psychedelic research. He is a co-founder and director at Entheos Labs, as well as the Chief Medical Advisor for the company.34
Professional Background
Dr. Rosenbaum has an extensive career in psychiatry:
- He served as the Stanley Cobb Professor of Psychiatry at Harvard Medical School.1
- For 20 years, he chaired the Massachusetts General Hospital Psychiatry Department.1
- He founded and currently directs the Center for the Neuroscience of Psychedelics at the Mass General Department of Psychiatry.4
Entrepreneurial Ventures
In addition to his academic and clinical work, Dr. Rosenbaum has been involved in several entrepreneurial ventures:
- Co-founder and Director at Entheos Labs (founded in 2022)5
- Co-founder and Director at Sensorium Therapeutics5
- Co-founder and Director at Psy Therapeutics, Inc.6
Education
Dr. Rosenbaum attended Yale College from 1965 to 1969.5
Current Focus
Dr. Rosenbaum's current work focuses on understanding how psychedelics can enhance the brain's capacity for change and developing new treatments for mental illness. His goal is to optimize current treatments and ultimately render the term "treatment resistant" obsolete in psychiatry.1
On LinkedIn, Jerry Rosenbaum can be found under the username jerry-rosenbaum-56177a8, where he has 5K followers and over 500 connections.2
